Por favor, inténtelo con una nueva búsqueda
Índice | Cierre | Máximo | Mínimo | Var. | Var % | Hora | ||
---|---|---|---|---|---|---|---|---|
HS CAHPI | 145.33 | 145.91 | 144.60 | +0.14 | +0.10% | 30/04 | ||
Hang Seng China AH A+H | 2,119.25 | 2,137.37 | 2,114.75 | -6.25 | -0.29% | 30/04 | ||
Hang Seng China AH H | 1,767.55 | 1,786.87 | 1,760.51 | -6.83 | -0.38% | 30/04 | ||
Hang Seng Comp I | 2,659.03 | 2,678.31 | 2,647.36 | +0.45 | +0.02% | 30/04 | ||
Hang Seng CSC | 1,177.90 | 1,181.85 | 1,168.91 | +1.11 | +0.09% | 30/04 | ||
HS Healthcare | 2,286.03 | 2,321.92 | 2,276.88 | -19.02 | -0.83% | 30/04 | ||
Hang Seng Healthcare | 7,332.74 | 7,448.11 | 7,302.92 | -60.00 | -0.81% | 30/04 | ||
HS Hong Kong-Listed Biotech | 807.51 | 820.81 | 804.21 | -7.52 | -0.92% | 30/04 | ||
HS Composite LargeCap & MidCap | 2,795.88 | 2,816.88 | 2,783.99 | +0.38 | +0.01% | 30/04 | ||
HS Stock Connect Hong Kong | 2,652.11 | 2,668.82 | 2,640.42 | +3.08 | +0.12% | 30/04 | ||
HS Stock Connect Hong Kong SmallCap | 1,752.40 | 1,758.86 | 1,739.63 | +2.09 | +0.12% | 30/04 | ||
HS Innovative Drug | 1,547.21 | 1,573.06 | 1,535.38 | -13.78 | -0.88% | 30/04 | ||
HS Stock Connect China AH Smart | 4,386.45 | 4,432.27 | 4,367.67 | -14.71 | -0.33% | 30/04 | ||
HS Composite MidCap & SmallCap | 2,098.11 | 2,110.84 | 2,087.43 | -1.58 | -0.08% | 30/04 | ||
HS SCHK ML CN Companies | 2,624.88 | 2,649.30 | 2,613.36 | -3.73 | -0.14% | 30/04 | ||
HS Small Cap | 1,538.71 | 1,544.48 | 1,527.53 | +1.77 | +0.12% | 30/04 | ||
HS SCHK Innovative Drug Select | 1,219.35 | 1,242.13 | 1,215.30 | -15.98 | -1.29% | 30/04 | ||
HS SCHK Innovative Drug | 1,744.29 | 1,775.02 | 1,736.79 | -19.61 | -1.11% | 30/04 |
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Díganos qué piensa de este comentario
Gracias
Su denuncia será examinada por nuestros moderadores